Clinical medicine (London, England)
-
Observational Study
Outcomes from a virtual ward delivering oxygen at home for patients recovering from COVID-19: a real world observational study.
There is a lack of data on the safety of providing oxygen at home to stable patients recovering from COVID-19. ⋯ Provision of oxygen at home for selected patients recovering from COVID-19 is safe with low risk of readmission and death.
-
Lymphocytosis is a common blood-test finding. Establishing whether the cause of lymphocytosis is benign or malignant is key to managing patients appropriately. A lymphocytosis should always prompt clinical review including a thorough history, examination and appropriate preliminary investigations (blood tests, blood film). ⋯ Patient outcomes vary considerably based on genetic pre-disposition and various prognostic markers (age, Binet or Rai staging, and B2-microglobulin). Although not curative, chemo-immunotherapy is an effective treatment strategy for the majority of CLL patients with progressive disease. More recently, novel oral therapies have been developed that target key signalling and apoptosis pathways and that are being used in relapse settings and as first-line treatments for certain patients.
-
Comment Letter
The association of pleural effusion and pulmonary embolism.